Articles
Pharmaceuticals and Life Sciences: what will 2025 bring?
12 Dec 2024As things quieten down for the end of the year (ha ha, one day maybe but not 2024!), it is good to reflect on what is next. In this article, we have pointed towards a few key developments to watch out for in 2025.
Court of Appeal rules on how to calculate damages in liability clause
12 Dec 2024Clarifying liability caps: Key lessons from the Topalsson v Rolls Royce case
Research and development subsidies - report into the £129 million grant funding to BioNTech for the life sciences sector
02 Dec 2024This blog examines the Subsidy Advice Unit (SAU) report into a proposed subsidy by the Department of Science Innovation and Technology (DSIT) to BioNTech UK Limited (BioNTech).
Life Sciences and sustainability shine in new UK industrial strategy
19 Nov 2024"Growth is the number one mission of this government. Our new Industrial Strategy is central to that Growth Mission". So starts the Green Paper setting out the new UK Government's vision for an Industrial Strategy that plans to 2035 and beyond.
Protecting data: implications of the Cyber Security and Resilience Bill for the UK's pharmaceuticals and life sciences sector
19 Nov 2024The proposed Cyber Security and Resilience Bill (the Bill) intends to capture more sectors, increase incident reporting and strengthen ICO powers - we consider the potential implications for the UK's pharmaceuticals and Life Sciences sector.
AI and copyright - moving closer to a solution?
19 Nov 2024Lawmakers are addressing how to govern the use of copyrighted materials for training AI models. This article examines the situation in the UK and Europe.
